Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B7448 VU 0238429Summary: positive allosteric modulator of M5 receptors
- B7451 A 987306Summary: H4 receptor antagonist,potent and selective
- B7476 (RS)-MCPG disodium saltSummary: group I/group II metabotropic glutamate receptor antagonist
- B7487 VU 0255035Summary: muscarinic M1 antagonist
- B7488 PristimerinSummary: monoacylglycerol lipase (MGL) inhibitor
- B7495 A 943931 dihydrochlorideSummary: Antagonist of histamine H4 receptor,potent and selective
- B7511 CCMISummary: Positive allosteric modulator of α7 neuronal nicotinic acetylcholine receptors (nAChR)
- B7524 PG 01037 dihydrochlorideSummary: Dopamine D3 receptor antagonist
- B7533 SC 236Summary: COX-2 inhibitor
- B7543 GSK 789472 hydrochlorideSummary: dopamine D3 receptor antagonist and D2 partial agonist